CASC

Cascadian Therapeutics, Inc.
CASC

Overview Fund Activity
Delisted

CASC was delisted on the 8th of March, 2018.

Back to rankings

86 hedge funds and large institutions have $98.5M invested in Cascadian Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 17 reducing their positions, and 13 closing their positions.

Holders
86
Holders Change
–
Holders Change %
0%
% of All Funds
2.3%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
14
Increased
35
Reduced
17
Closed
13
Calls
$463K
Puts
$201K
Net Calls
+$262K
Net Calls Change
-$552K

Top Buyers

1
BI
1
BVF Inc
California
$26.1M
2
BC
2
Broadfin Capital
New York
$3.8M
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$1.25M
4
OAM
4
Oxford Asset Management
United Kingdom
$605K
5
BFA
5
BlackRock Fund Advisors
California
$4.26M

Top Sellers

1
GPP
1
Great Point Partners
Connecticut
$0
2
DM
2
Deerfield Management
New York
$757K
3
QF
3
QVT Financial
New York
$9.48M
4
ERSOT
4
Employees Retirement System of Texas
Texas
$0
5
GTC
5
Ghost Tree Capital
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SF
101
Synovus Financial
Georgia
$0 166 +166 New
1 2 3 4
5